BridgeMD
New treatment option for Generalized Anxiety Disorder
Official title Group vs. Individual Metacognitive Therapy for Generalized Anxiety Disorder
ClinicalTrials.gov ID: NCT07579897
What this study is testing
- What it's testing
- Generalized anxiety disorder (GAD) is a serious and long-lasting condition that can greatly reduce quality of life, work functioning, and use of health services. Metacognitive therapy (MCT) is an effective treatment for GAD, but it is not yet known whether individual MCT or group-based MCT provides the best results for patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults with a primary diagnosis of generalized anxiety disorder (GAD). GAD-7 score ≥ 10 at screening/baseline. Participants must endorse that they...
You likely can't join if
- Bipolar disorder;
- Psychosis;
- Ongoing substance abuse/dependence;
- Intellectual disability based on previous medical history;
- Eating disorder in need of medical attention;
- Unwillingness to refrain from anxiolytic drugs during the treatment;
See the full eligibility criteria
- Adults with a primary diagnosis of generalized anxiety disorder (GAD). GAD-7 score ≥ 10 at screening/baseline. Participants must endorse that they experience problems with excessive worry
- Bipolar disorder;
- Psychosis;
- Ongoing substance abuse/dependence;
- Intellectual disability based on previous medical history;
- Eating disorder in need of medical attention;
- Unwillingness to refrain from anxiolytic drugs during the treatment;
- Current suicidal ideation with plan and intent;
- Taking an unstable dose of antidepressant, with recent dose-change within the last 4 weeks;
- Known cluster A or B personality disorder;
- Serious medical comorbidity (e.g.: cancer, severe renal failure)
- Language difficulties in need of an interpreter.
The study team makes the final eligibility decision.
Where it's taking place
- Kristiansand, Agder, Norway
- Kristiansand, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kristiansand, Agder, Norway; Kristiansand, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.